Peripheral/Endo

PatenSee Receives FDA Breakthrough Device Designation for Non-Contact Vascular Access Management for Patients Undergoing Hemodialysis

Designation supports accelerated development of AI-driven platform to improve outcomes and reduce clinical burden. DETROIT and OR YEHUDA, Israel, Sept. 16, 2025 /PRNewswire/ — PatenSee, a clinical-stage medical device company, announced that the U.S. Food and Drug Administration (FDA)…

Johnson & Johnson Announces Launch of its Shockwave Javelin Peripheral Intravascular Lithotripsy Catheter in Europe to Transform Treatment of Difficult-to-Cross Calcified Lesions

  SANTA CLARA, Calif. – September 15, 2025 – Today, Johnson & Johnson announced the European launch of its Shockwave Javelin Peripheral IVL Catheter, a novel intravascular lithotripsy (IVL) platform designed to modify calcium in extremely narrowed vessels to expand treatments in patients suffering from peripheral artery disease (PAD). The first-of-its-kind Forward IVL […]

Late Breaking Clinical Trial from AVS IVL Pivotal Study to be Presented at VIVA

POWER PAD II IDE trial evaluates safety and efficacy of the Pulse IVL™ system in patients with severely calcified peripheral arterial disease BOSTON–(BUSINESS WIRE)–Amplitude Vascular Systems (AVS), a medical device company focused on safely and effectively treating severely calcified arterial disease, announced today that it will present 30-day results of its […]

Shape Memory Medical Completes Enrollment in the EMBO-Post Market Surveillance Registry

SAN JOSE, Calif.–(BUSINESS WIRE)–Shape Memory Medical Inc., the innovator of shape memory polymer for endovascular applications, announced the completion of patient enrollment in the EMBO Post Market Surveillance (EMBO-PMS) Registry, the Company’s prospective, multicenter registry of the IMPEDE and IMPEDE-FX Embolization Plugs, and IMPEDE-FX RapidFill Device when used for peripheral […]